HBT
REGN icon

Heartland Bank & Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Heartland Bank & Trust’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-578
Closed -$412K – 182
2024
Q4 		$412K Sell
578
-30
-5% -$25.2K 0.22% 92
2024
Q3 		$639K Sell
608
-16
-3% -$17.8K 0.34% 71
2024
Q2 		$656K Sell
624
-286
-31% -$277K 0.37% 63
2024
Q1 		$876K Buy
910
+4
+0.4% +$3.8K 0.51% 45
2023
Q4 		$796K Sell
906
-86
-9% -$70.8K 0.55% 44
2023
Q3 		$816K Buy
992
+87
+10% +$68.4K 0.64% 36
2023
Q2 		$650K Buy
905
+480
+113% +$370K 0.51% 51
2023
Q1 		$349K Sell
425
-543
-56% -$410K 0.26% 106
2022
Q4 		$698K Buy
968
+1
+0.1% +$738 0.52% 44
2022
Q3 		$666K Sell
967
-135
-12% -$85K 0.64% 49
2022
Q2 		$651K Buy
1,102
+68
+7% +$44.2K 0.58% 57
2022
Q1 		$722K Buy
1,034
+711
+220% +$450K 0.55% 61
2021
Q4 		$204K Buy
+323
New +$199K 0.15% 125
2021
Q2 		– Sell
-1,623
Closed -$768K – 150
2021
Q1 		$768K Buy
1,623
+570
+54% +$278K 0.7% 48
2020
Q4 		$509K Buy
+1,053
New +$568K 0.45% 66

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Heartland Bank & Trust's REGN Position: Q1 2025 in Review

Heartland Bank & Trust sold out of Regeneron Pharmaceuticals (REGN) in Q1 2025, closing a stake of 578 shares — an estimated $412K sold.

Heartland Bank & Trust first reported a position in REGN in Q4 2020 and held it in 15 quarters. The position peaked at $876K in Q1 2024. 1,292 funds tracked by Wall St. Rank hold REGN as of Q1 2025.

  • Heartland Bank & Trust reported no remaining Regeneron Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Heartland Bank & Trust sold 578 Regeneron Pharmaceuticals shares in Q1 2025, an estimated $412K.
  • Heartland Bank & Trust first reported a position in Regeneron Pharmaceuticals in Q4 2020 and held it in 15 quarters.
  • Heartland Bank & Trust's Regeneron Pharmaceuticals position peaked at $876K in Q1 2024.
  • 1,292 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2025.

Based on Heartland Bank & Trust's 13F filing for Q1 2025, filed 22 Apr 2025.